Prescription drug · ANDA
Zidovudine NDC 65862-048
Zidovudine 10 mg/mL · Syrup · Oral · Aurobindo Pharma Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 65862-048-24 | 65862004824 | 240 mL in 1 BOTTLE (65862-048-24)Marketed from Sep 19, 2005 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Zidovudine
- Generic name (nonproprietary)
- zidovudine
- Active ingredients
- Zidovudine — 10 mg/mL
- Dosage form
- Syrup
- Route
- Oral
- Labeler
- Aurobindo Pharma LimitedNDC labeler code 65862
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 077268
- Marketing start
- Listing expires
- Other FDA classes
- Nucleoside Reverse Transcriptase Inhibitors (Mechanism)
- Identifiers
- Product ID 65862-048_19584bb3-e849-4839-961f-c38bb07a4e8cSPL ID 19584bb3-e849-4839-961f-c38bb07a4e8cSPL set ID 51abd2ce-6be1-412d-b806-5f24935ac5e3RxCUI 756209UNII 4B9XT59T7SUPC 0365862048240
- Pharmacologic class
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N465862004824followed by a unit qualifier and the quantityPackage 65862-0048-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Zidovudine oral solution is a nucleoside analogue reverse transcriptase inhibitor indicated for: Treatment of Human Immunodeficiency Virus (HIV-1) infection in combination with other antiretroviral agents. (1.1) Prevention of maternal-fetal HIV-1 transmission. (1.2) 1.1 Treatment of HIV-1 Zidovudine oral solution, a nucleoside reverse transcriptase inhibitor, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. 1.2 Prevention of Maternal-Fetal HIV-1 Transmission Zidovudine oral solution is indicated for the prevention of maternal-fetal HIV-1 transmission [see Dosage and Administration (2.3) ]. The indication is based on a dosing regimen that incl…
Excerpt only. Read the full label for complete information.
About NDC 65862-048
- What is NDC 65862-048?
- 65862-048 is the product NDC for Zidovudine, Zidovudine 10 mg/mL syrup, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Zidovudine.
- What is the active ingredient?
- Zidovudine.
- Who is the labeler?
- Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Zidovudine?
- 2 other product NDCs are listed under this name. See all Zidovudine NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Zidovudine products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Zidovudine | Zidovudine 300 mg/1 | TabletOral | Coupler LLC | 67046-1613 | 67046-1613-03 |
| Zidovudine | Zidovudine 300 mg/1 | TabletOral | Camber Pharmaceuticals, Inc. | 31722-509 | 31722-0509-60 |